Practical Steps for Centralized Monitoring Success
The successful implementation of Centralized Monitoring requires meticulous planning, process reform and alignment, cross-functional expertise, and most importantly the right technology in place. With regulators…
Read More
The Evolution of CluePoints’ SMART Engine
How C++ Revolutionized the Core of CluePoints With software playing an integral part of almost every device that makes daily life easier, the same is…
Read More
CluePoints Opens New APAC Office in Tokyo
King of Prussia, PA – December 8th, 2020: CluePoints, the premier provider of Central Statistical Monitoring, Risk-Based Quality Management and Data Quality Oversight Software for…
Read More
Life as a Clinical Data Analyst at CluePoints
Life as a clinical data analyst at CluePoints is anything but dull – so when I was asked to talk about a typical day, it…
Read More
Best Practice Advice to Enable Teams to Focus on High Quality Data in Clinical Studies
BioPharma studies are as vast as they are pioneering, with many different teams within many different groups across many organizations all playing a part in…
Read More
Exploring the role of AI and Machine Learning in Clinical Trials
We live in a rapidly evolving digital era shaped by a continuous stream of pioneering technological advances. The world of clinical research is no exception,…
Read More
Centralized Monitoring – How to Unlock the Treasure Chest of Analytical Insights
Chief Scientific Officer of CluePoints, Steve Young, discusses his thoughts on how Centralized monitoring has started to take off in the clinical trials industry even…
Read More
Applying Risk-Based Quality Management to Investigator-Led Trials
Medical science is advancing at a never before seen rate, but costs are spiralling meaning clinical trials need to change if they are to ensure…
Read More
CluePoints Joins Forces with Global Growth Investor Summit Partners to Expand Market Leadership Position in Risk-Based Quality Management
LOUVAIN-LA-NEUVE, BELGIUM; KING OF PRUSSIA, PA; and LONDON, UK (September 1, 2020) – CluePoints S.A., a provider of Risk-Based Study Execution (RBx) and Data Quality…
Read More
Events
Find out where we’re headed next.
Featured Whitepaper
ICH E6 (R2)
Summary
Paper
Created in conjunction with our peers at TUFTS Center for the Study of Drug Development, this paper provides insights on how companies are responding to ICH E6 (R2) and information on the key themes on adoption.
Featured Webinar
ICH E6 (R2)
Webinar
Series
This recorded webinar covers all of the frequently asked Questions about ICH E6 (R2), Risk-Based Study Execution (RBx) and what’s required from a people, process & technology standpoint.
We're Kind of a Big Deal.
2,500
Platform Users
350
Studies De-Risked
15,000
Issues Detected